Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis

NCT06767150 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06767150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06767150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Recruiting
Start date
October 2, 2025
Completion date
October 31, 2030
Enrollment
200 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis